A Study of HRS-4642 Monotherapy or in Combination With Adebrelimab in the Treatment of Advanced Biliary Tract Tumors.
Clinical trial NCT06620848 · RECRUITING
Trial details
- NCT number
- NCT06620848
- Sponsor
- Shanghai Zhongshan Hospital
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-11-21
- Primary completion
- 2026-12-31
- Enrollment
- 49
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.